FCH-2296413 is a potent and selective hydroxycarboxylic acid receptor ( HCAR ) agonist with an EC 50 of 4.4-8.6 nM. FCH-2296413 exhibits analgesic activity and can be used for the research of peripheral pain-related diseases [1].
References:
[1]. Kang HJ, et al. Structure-guided design of a peripherally restricted chemogenetic system. Cell. 2024 Dec 26;187(26):7433-7449.e20.
References:
[1]. Kang HJ, et al. Structure-guided design of a peripherally restricted chemogenetic system. Cell. 2024 Dec 26;187(26):7433-7449.e20.
















